Posted on 9월 5, 20249/5/24
The Promise of a Direct-to-Patient Model – Breaking Down What’s Really Needed for Better Patient Access
Posted on 8월 13, 20248/13/24
IDN Trends, Insights and Strategies Every Manufacturer Should Know
Posted on 7월 8, 20247/8/24
Report: Integrated Delivery Network Trends and Engagement Strategies Every Drug Manufacturer Needs to Know
Posted on 6월 28, 20246/28/24
European Parliament’s Revision of the General Pharmaceutical Legislation
Posted on 6월 24, 20246/24/24
Market Access and the Inflation Reduction Act
Posted on 6월 21, 20246/21/24
Optimizing Product Commercialization in Today’s IDN Environment
Posted on 6월 3, 20246/3/24
Navigating the Evolution of Precision Medicine: Data-Driven Strategies for Life Sciences Commercialization
Posted on 5월 23, 20245/23/24
Bridging “Share of Voice” with “Share of Influence” for Lasting Impact
Posted on 5월 23, 20245/23/24
Integrated Delivery Networks (IDNs): Driving Change in Drug Access and Utilization
Posted on 2월 14, 20242/14/24